宇能制药 (873992.oc)

+ 收藏

现金流量表(宇能制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2023年一季报2022年年报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 144,917,514.0361,334,406.6219,856,688.27129,949,492.0626,894,620.24987,801.14
 收到其他与经营活动有关的现金(元) 7,005,485.764,459,679.752,369,345.791,817,566.27645,630.6813,411,639.89
 经营活动现金流入的平衡项目(元) -----8,886,000.00
 经营活动现金流入小计(元) 151,922,999.7965,794,086.3722,226,034.06131,767,058.3327,540,250.9223,285,441.03
 购买商品、接受劳务支付的现金(元) 69,301,625.0834,138,917.0820,236,371.6681,439,834.307,125,459.7117,750,391.20
 支付给职工以及为职工支付的现金(元) 16,961,824.378,655,985.984,897,453.1612,952,901.558,601,900.212,606,488.51
 支付的各项税费(元) 16,831,373.2812,575,250.738,225,151.004,668,516.821,276,961.081,040,479.29
 支付其他与经营活动有关的现金(元) 11,907,795.326,489,085.432,499,067.4410,773,806.374,688,415.415,804,055.21
 经营活动现金流出小计(元) 115,002,618.0561,859,239.2235,858,043.26109,835,059.0421,692,736.4127,201,414.21
 经营活动产生的现金流量净额(元) 36,920,381.743,934,847.15-21,931,999.295,847,514.51-
二、投资活动产生的现金流量
 购建固定资产、无形资产和其他长期资产支付的现金(元) 22,699,657.3713,766,198.737,569,076.0322,568,982.1929,111,051.35-
 投资活动现金流出小计(元) 22,699,657.3713,766,198.737,569,076.0322,568,982.1929,111,051.35-
 投资活动产生的现金流量净额(元) -22,699,657.37-13,766,198.73-7,569,076.03-22,568,982.19-29,111,051.35-
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 18,911,919.93--33,000,000.0033,000,000.00-
 取得借款收到的现金(元) 35,000,000.0035,000,000.0029,000,000.0046,325,000.0025,000,000.0015,000,000.00
 收到其他与筹资活动有关的现金(元) ---4,000,000.00--
 筹资活动现金流入小计(元) 53,911,919.9335,000,000.0029,000,000.0083,325,000.0058,000,000.0015,000,000.00
 偿还债务支付的现金(元) 56,325,000.0046,325,000.0015,000,000.0032,400,000.0027,700,000.0010,002,672.23
 分配股利、利润或偿付利息支付的现金(元) 18,675,959.3718,098,856.02509,903.841,915,367.591,026,129.79422,173.62
 支付其他与筹资活动有关的现金(元) 148,250.0086,750.00-4,173,500.0086,750.00-
 筹资活动现金流出小计(元) 75,149,209.3764,510,606.0215,509,903.8438,488,867.5928,812,879.7910,424,845.85
 筹资活动产生的现金流量净额(元) -21,237,289.44-29,510,606.0213,490,096.1644,836,132.4129,187,120.214,575,154.15
四、汇率变动对现金及现金等价物的影响(元) -7.85--3.41-
五、现金及现金等价物净增加额(元) -7,016,565.07-39,341,949.75-7,710,989.0744,199,149.515,923,586.78659,180.97
 加:期初现金及现金等价物余额(元) 45,208,855.0545,208,855.0545,208,855.051,009,705.541,009,705.541,009,705.54
 期末现金及现金等价物余额(元) 38,192,289.985,866,905.3037,497,865.9845,208,855.056,933,292.321,668,886.51
补充资料:
 净利润(元) 50,531,143.5625,464,956.11-23,622,896.11-959,263.82-
 资产减值准备(元) 396,750.30-5,777.74-9,199.433,143.25-
 固定资产和投资性房地产折旧(元) 6,506,869.163,255,765.04-4,441,866.331,425,746.58-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 6,506,869.163,255,765.04-4,441,866.331,425,746.58-
 无形资产摊销(元) 5,519.522,759.76-5,519.522,759.76-
 固定资产报废损失(元) 225,140.94-----
 财务费用(元) 1,528,013.61954,647.78-1,840,594.62961,188.13-
 投资损失(元) ---95,461.75--
 递延所得税(元) 169,648.08-123,583.74--296,574.47-1,004,922.52-
  其中:递延所得税资产减少(元) 158,026.47-123,583.74--288,736.60-1,004,922.52-
 递延所得税负债增加(元) 11,621.61---7,837.87--
 存货的减少(元) -26,055,632.28-10,151,107.54--14,442,748.54-6,682,771.36-
 经营性应收项目的减少(元) -291,228.60-15,436,889.32--11,577,870.21-13,407,537.73-
 经营性应付项目的增加(元) 3,362,013.68-1,675,867.31-15,831,741.3123,158,805.33-
 其他(元) 118,609.83695,464.89-2,247,965.742,003,647.22-
 不涉及现金收支的投资和筹资活动金额其他项目(元) 211,800.63-----
 现金的期末余额(元) 38,192,289.985,866,905.30-45,208,855.056,933,292.32-
 减:现金的期初余额(元) 45,208,855.0545,208,855.05-1,009,705.541,009,705.54-
 现金及现金等价物的净增加额(元) -7,016,565.07-39,341,949.75-44,199,149.515,923,586.78-
公告日期 2024-03-292023-08-282023-07-122023-03-312023-08-282023-07-12
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院